322 related articles for article (PubMed ID: 31302962)
1. [Analysis on risk factors of positive vertical resection margin after endoscopic treatment of rectal neuroendocrine tumors].
Wang RG; Jiang X; Ren YT; Wang J; Guo XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):643-647. PubMed ID: 31302962
[No Abstract] [Full Text] [Related]
2. [Application of dental floss traction-assisted endoscopic submucosa dissection to rectal neuroendocrine neoplasm].
Shi Q; Sun D; Zhong YS; Xu MD; Li B; Cai SL; Qi ZP; Ren Z; Zhang H; Yong YY; Yao LQ; Zhou PH
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):377-382. PubMed ID: 31054553
[No Abstract] [Full Text] [Related]
3. Endoloop ligation after endoscopic mucosal resection using a transparent cap: A novel method to treat small rectal carcinoid tumors.
Zhang DG; Luo S; Xiong F; Xu ZL; Li YX; Yao J; Wang LS
World J Gastroenterol; 2019 Mar; 25(10):1259-1265. PubMed ID: 30886508
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis.
Zheng JC; Zheng K; Zhao S; Wang ZN; Xu HM; Jiang CG
Z Gastroenterol; 2020 Feb; 58(2):137-145. PubMed ID: 32050284
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment.
Cha B; Shin J; Ko WJ; Kwon KS; Kim H
BMC Gastroenterol; 2022 Jun; 22(1):293. PubMed ID: 35681149
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
[TBL] [Abstract][Full Text] [Related]
7. EMR-P for small rectal neuroendocrine tumors: is it a preferred treatment?
Liu Z; Zheng C; Ding S; Chen C; Yang J; Wu R; Sun D
Scand J Gastroenterol; 2022 Dec; 57(12):1503-1508. PubMed ID: 35758188
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes of endoscopic submucosal dissection in rectal neuroendocrine tumors based on resection margin status: a real-world study.
Sun D; Ren Z; Xu E; Cai S; Qi Z; Chen Z; Liu J; Shi Q; Zhou P; Zhong Y
Surg Endosc; 2023 Apr; 37(4):2644-2652. PubMed ID: 36380122
[TBL] [Abstract][Full Text] [Related]
9. Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors.
Park SB; Kim HW; Kang DH; Choi CW; Kim SJ; Nam HS
World J Gastroenterol; 2015 Aug; 21(31):9387-93. PubMed ID: 26309365
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of endoscopic resection for rectal carcinoid tumors: an analysis of the resectability and long-term results from 46 consecutive cases.
Kaneko H; Hirasawa K; Koh R; Kobayashi R; Kokawa A; Tanaka K; Maeda S
Scand J Gastroenterol; 2016 Dec; 51(12):1489-1494. PubMed ID: 27687741
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for positive resection margins after endoscopic resection for gastrointestinal neuroendocrine tumors.
Han L; Li J; Liang C; Chu Y; Wang Y; Lv L; Liu D; Tan Y
Surg Endosc; 2024 Apr; 38(4):2041-2049. PubMed ID: 38429572
[TBL] [Abstract][Full Text] [Related]
12. Comparison between endoscopic mucosal resection with a cap and endoscopic submucosal dissection for rectal neuroendocrine tumors.
Zheng X; Wu M; Shi H; Er L; Wang K; Cao Y; Li S
BMC Surg; 2022 Jun; 22(1):248. PubMed ID: 35761304
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
[TBL] [Abstract][Full Text] [Related]
14. [Transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors].
Shao Q; Lin G; Qiu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1009-1014. PubMed ID: 28900991
[TBL] [Abstract][Full Text] [Related]
15. The clinical outcomes and risk factors associated with incomplete endoscopic resection of rectal carcinoid tumor.
Choi CW; Park SB; Kang DH; Kim HW; Kim SJ; Nam HS; Ryu DG
Surg Endosc; 2017 Dec; 31(12):5006-5011. PubMed ID: 28936630
[TBL] [Abstract][Full Text] [Related]
16. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of endoscopic mucosal resection using a dual-channel endoscope compared with endoscopic submucosal dissection in the treatment of rectal neuroendocrine tumors.
Lee WH; Kim SW; Lim CH; Kim JS; Cho YK; Lee IS; Choi MG; Choi KY
Surg Endosc; 2013 Nov; 27(11):4313-8. PubMed ID: 23807754
[TBL] [Abstract][Full Text] [Related]
18. [Endoscopic Treatment Outcome of Rectal Neuroendocrine Tumors Removed by Ligation-assisted Endoscopic Submucosal Resection].
Gu MG; Lee SH
Korean J Gastroenterol; 2018 Sep; 72(3):128-134. PubMed ID: 30270594
[TBL] [Abstract][Full Text] [Related]
19. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors.
Ebi M; Nakagawa S; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Shimura T; Funaki Y; Ogasawara N; Sasaki M; Joh T; Kasugai K
Int J Colorectal Dis; 2018 Dec; 33(12):1703-1708. PubMed ID: 30167779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
